Adore: A Randomized, Open-Label, Phase 1/2 Open-Platform Study Evaluating Safety and Efficacy of Novel Ruxolitinib Combinations in Patients with Myelofibrosis

被引：5
|
作者：
Perkins, Andrew Charles
Burbury, Kate
Lehmann, Thomas
Ross, David M.
Reiter, Andreas
Gupta, Vikas
Harrison, Claire
Kiladjian, Jean-Jacques
Vannucchi, Alessandro M.
Wondergem, Marielle
Pack, Robert
Wroclawska, Monika
Wilke, Celine
Zhang, Angela
Heidel, Florian H.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140408
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] A Randomized, Open-Label, Multicenter, Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of KRT-232 Compared with Ruxolitinib in Patients with Phlebotomy-Dependent Polycythemia Vera
    Gotlib, Jason
    Gabrail, Nashat
    O'Connell, Casey L.
    Garcia-Delgado, Regina
    Sbardellati, Timothy
    Rothbaum, Wayne M.
    McGreivy, Jesse
    Harrison, Claire N.
    Kiladjian, Jean-Jacques
    BLOOD, 2019, 134
  • [32] Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors
    Gordon, Michael S.
    Nemunaitis, John
    Barve, Minal
    Wainberg, Zev A.
    Hamilton, Erika P.
    Ramanathan, Ramesh K.
    Sledge, George W., Jr.
    Yue, Huibin
    Morgan-Lappe, Susan E.
    Blaney, Martha
    Kasichayanula, Sreeneeranj
    Motwani, Monica
    Wang, Lan
    Naumovski, Louie
    Strickler, John H.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (10) : 1988 - 1995
  • [33] Results from HARMONY: an open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis
    Durrant, Simon T.
    Nagler, Arnon
    Guglielmelli, Paola
    Lavie, David
    le Coutre, Philipp
    Gisslinger, Heinz
    Chuah, Charles
    Maffioli, Margherita
    Bharathy, Savita
    Dong, Tuochuan
    Wroclawska, Monika
    Martinez Lopez, Joaquin
    HAEMATOLOGICA, 2019, 104 (12) : E551 - E554
  • [34] A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
    Anthony W. Tolcher
    Leonard J. Appleman
    Geoffrey I. Shapiro
    Alain C. Mita
    Frank Cihon
    Arthur Mazzu
    Pavur R. Sundaresan
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 751 - 764
  • [35] A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
    Tolcher, Anthony W.
    Appleman, Leonard J.
    Shapiro, Geoffrey I.
    Mita, Alain C.
    Cihon, Frank
    Mazzu, Arthur
    Sundaresan, Pavur R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 751 - 764
  • [36] Phase 1 open-label study evaluating pharmacokinetics, safety, and tolerability of linifanib in Japanese patients with solid tumors
    Tamura, Tomohide
    Yamamoto, Noboru
    Nokihara, Hiroshi
    Yamada, Yasuhide
    Asahina, Hajime
    Shibata, Takashi
    Goto, Yasushi
    Tanioka, Maki
    Tamura, Yosuke
    Seki, Yoshitaka
    Chiu, Yi-Lin
    Gupta, Neeraj
    Carlson, Dawn
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [37] Safety and Efficacy of Ruxolitinib in an Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (MF): An 1144-Patient Update
    Martino, Bruno
    le Coutre, Philipp
    Griesshammer, Martin
    Illmer, Thomas
    Schlag, Rudolf
    Waller, Cornelius F.
    Liberati, Anna Marina
    Schafhausen, Philippe
    Tavares, Renato S.
    Vannucchi, Alessandro M.
    Giraldo, Pilar
    Foltz, Lynda M.
    Raanani, Pia
    Gupta, Vikas
    Tannir, Bayane
    Ronco, Julian Perez
    Ghosh, Jaggannath
    Al-Ali, Haifa Kathrin
    BLOOD, 2014, 124 (21)
  • [38] SAFETY AND EFFICACY OF RUXOLITINIB (RUX) IN PATIENTS WITH INTERMEDIATE-1-RISK MYELOFIBROSIS (MF) FROM AN OPEN-LABEL, MULTICENTER, SINGLE-ARM EXPANDED-ACCESS STUDY
    Giraldo, P.
    Palandri, F.
    Palumbo, G. A.
    Zaritskey, A.
    Calistri, E.
    Skotnicki, A.
    Devos, T.
    Saavedra, D.
    Griesshammer, M.
    Al-Ali, H. K.
    Tavares, R.
    Vannucchi, A. M.
    Gupta, V.
    Raanani, P.
    Tannir, B.
    Ghosh, J.
    Ronco, J. Perez
    Foltz, L.
    HAEMATOLOGICA, 2015, 100 : 265 - 265
  • [39] Safety and Efficacy of Ruxolitinib in an 1869-Patient Cohort of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis
    Tavares, Renato
    Palumbo, Giuseppe A.
    Le Coutre, Philipp
    Palanciri, Francesca
    Al-Ali, Haifa Kathrin
    Martino, Bruno
    Liberati, Anna Marina
    Crass Arich, Jose
    Breccia, Massimo
    Brittain, David
    Foltz, Lynda
    Griesshammer, Martin
    Raanani, Pia
    Gupta, Vikas
    Giraldo, Pilar
    Chosh, Jagannath
    Tannir, Bayane
    Ronco, Julian Perez
    Vannucchi, Alessandro M.
    BLOOD, 2015, 126 (23)
  • [40] Safety and Efficacy of Ruxolitinib for the Final Enrollment of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (N=2233)
    Foltz, Lynda
    Palumbo, Giuseppe A.
    Martino, Bruno
    Palandri, Francesca
    Al-Ali, Haifa Kathrin
    Liberati, Anna Marina
    Le Coutre, Philipp D.
    Vannucchi, Alessandro M.
    Garcia-Hernandez, Carmen
    Tavares, Renato
    Griesshammer, Martin
    Gupta, Vikas
    Raanani, Pia
    Giraldo, Pilar
    Bouard, Catherine
    Ronco, Julian Perez
    Khanna, Sadhvi
    Zaritskey, Andrey
    BLOOD, 2016, 128 (22)
12345